Trade

with

Meridian Bioscience Inc
(NASDAQ: VIVO)
AdChoices
17.44
-0.29
-1.64%
After Hours :
17.44
0.00
0.00%

Open

17.55

Previous Close

17.73

Volume (Avg)

133.05k (247.34k)

Day's Range

17.40-17.93

52Wk Range

17.12-27.72

Market Cap.

724.94M

Dividend Rate (Yield )

0.80 (4.53%)

Beta

1.33

Shares Outstanding

41.57M

P/E Ratio (EPS)

20.53 (0.85)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 188.69M

    • Net Income

    • 38.03M

    • Market Cap.

    • 724.94M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 18.69

    • PEG (Price/Earnings Growth) Ratio

    • 1.31

    • Beta

    • 1.33

    • Forward P/E

    • 19.80

    • Price/Sales

    • 3.90

    • Price/Book Value

    • 4.55

    • Price/Cash flow

    • 20.79

      • EBITDA

      • 62.94M

      • Return on Capital %

      • 20.42

      • Return on Equity %

      • 22.81

      • Return on Assets %

      • 20.42

      • Book Value/Share

      • 3.89

      • Shares Outstanding

      • 41.57M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.20 (7/31/2014)

      • Dividend Declaration Date

      • 7/24/2014

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 21.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 0.90

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.20

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • 14.00

          • -5.55

          • Net Income

            Q/Q (last year)

          • -13.00

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 6.21

          • 47.82

          • Net Income

            5-Year Annual Average

          • 4.70

          • 4.98

          • Dividends

            5-Year Annual Average

          • 7.48

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 62.65

            • 42.70

            • Pre-Tax Margin

            • 27.73

            • 11.63

            • Net Profit Margin

            • 18.69

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 62.80

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 29.30

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 19.40

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 6.70

              • 1.23

              • Quick Ratio

              • 3.84

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.10

              • 2.16

              • Book Value/Share

              • 3.89

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 20.66

                • 33.44

                • P/E Ratio 5-Year High

                • 32.67

                • 325.07

                • P/E Ratio 5-Year Low

                • 17.45

                • 154.73

                • Price/Sales Ratio

                • 3.86

                • 2.32

                • Price/Book Value

                • 4.51

                • 3.05

                • Price/Cash Flow Ratio

                • 20.79

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 22.81

                    (22.50)

                  • 9.34

                    (9.80)

                  • Return on Assets %

                    (5-Year Average)

                  • 20.42

                    (19.90)

                  • 4.63

                    (5.44)

                  • Return on Capital %

                    (5-Year Average)

                  • 22.81

                    (22.50)

                  • 5.73

                    (6.77)

                  • Income/Employee

                  • 64.93k

                  • 17.17k

                  • Inventory Turnover

                  • 1.98

                  • 5.07

                  • Asset Turnover

                  • 1.09

                  • 0.48

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  57.31M
                  Operating Margin
                  30.38
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  20.79
                  Ownership

                  Institutional Ownership

                  99.87%

                  Top 10 Institutions

                  56.20%

                  Mutual Fund Ownership

                  57.42%

                  Float

                  76.81%

                  5% / Insider Ownership

                  2.85%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Neuberger Berman Genesis Fund

                  •  

                    2,988,097

                  • -4.90

                  • 7.19

                  • Brown Capital Management Small Company

                  •  

                    2,263,554

                  • 0.00

                  • 5.45

                  • T. Rowe Price Small Cap Stock Fund

                  •  

                    1,851,900

                  • -0.49

                  • 4.46

                  • Fidelity® Series Equity-Income Fund

                  •  

                    1,280,700

                  • 112.69

                  • 3.08

                  • Perkins Small Capital Value Fund

                  •  

                    1,023,644

                  • 32.27

                  • 2.46

                  • Fidelity® Equity Income Fund

                  •  

                    926,700

                  • 87.81

                  • 2.23

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    834,480

                  • 0.93

                  • 2.02

                  • Broadview Opportunity Fund

                  •  

                    748,160

                  • 31.70

                  • 1.80

                  • Vanguard Small Cap Index

                  •  

                    722,742

                  • -0.22

                  • 1.74

                  • Vanguard Total Stock Mkt Idx

                  •  

                    675,463

                  • 0.19

                  • 1.62

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Brown Capital Management, LLC

                  •  

                    4,775,800

                  • +2.93%

                  • 11.49

                  • Neuberger Berman LLC

                  •  

                    3,700,454

                  • -7.10%

                  • 8.90

                  • Vanguard Group, Inc.

                  •  

                    2,797,623

                  • +2.86%

                  • 6.73

                  • T. Rowe Price Associates, Inc.

                  •  

                    2,557,305

                  • -2.85%

                  • 6.15

                  • BlackRock Fund Advisors

                  •  

                    2,110,406

                  • -7.15%

                  • 5.08

                  • Walter Scott & Partners Ltd

                  •  

                    1,510,874

                  • +16.60%

                  • 3.63

                  • Clifton Park Captial Management LLC

                  •  

                    1,400,000

                  • 0.00%

                  • 3.37

                  • Perkins Investment Management LLC.

                  •  

                    1,243,053

                  • +49.96%

                  • 2.99

                  • Boston Trust & Investment Management Co.

                  •  

                    1,209,346

                  • +1.23%

                  • 2.91

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Diagnostics & Research

                  Type

                  Classic Growth

                  Style

                  Small Core

                  Meridian Bioscience Inc was incorporated in Ohio in 1976. It is a fully-integrated life science company involved in the development, manufacture, sale and distribution of diagnostic test kits, mainly for certain respiratory, gastroin...moretestinal, viral and parasitic infectious diseases. It also manufactures and distributes bulk antigens, antibodies and reagents used by researchers and other diagnostic manufacturers and the contract development. The Company is involved in manufacturing of proteins and other biological products used by bio-pharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Companys operating segments are Diagnostics and Life Science. The Companys U.S. Diagnostics segment focuses on the development, manufacture, sale and distribution of diagnosti...morec test kits, primarily for certain gastrointestinal, viral, respiratory and parasitic infectious diseases. Its European Diagnostics segment focuses on the sale and distribution of diagnostic test kits, manufactured both by the Companys U.S. Diagnostics segment and by third-party vendors. Life Science segment focuses on the development, manufacture, sale and distribution of bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells and bio-research reagents used by researchers and other diagnostic companies, as well as contract development and manufacturing services under clinical cGMP conditions. It has operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany; and Sydney, Australia. The products in both segment includes Molecular tests, Immunoassay tests, Molecular components, Immunoassay components. The Companys competitors are Abbott Laboratories Inc., Becton, Dickinson and Company, Thermo Fisher and Siemens, Quidel Corporation and Inverness Medical Innovations. The diagnostic products are regulated by the Food & Drug Administration (FDA) as devices pursuant to the Federal Food, Drug, and Cosmetic Act (FDC).lessless

                  Key People

                  John A. Kraeutler

                  CEO/Director

                  William J. Motto

                  Chairman of the Board/Director/Founder

                  Melissa A. Lueke

                  CFO/Chief Accounting Officer/Executive VP/Secretary

                  Mr. Marco G. Calzavara

                  Managing Director, Subsidiary/President

                  Lawrence J. Baldini

                  Executive VP, Divisional

                  • Meridian Bioscience Inc

                  • 3471 River Hills Drive

                  • Cincinnati, OH 45244

                  • USA.Map

                  • Phone: +1 513 271-3700

                  • Fax: +1 513 271-3762

                  • meridianbioscience.com

                  Incorporated

                  1976

                  Employees

                  550

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: